Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Elimination of Health Disparities Through Translation Research (Panel D), Funding Opportunity Announcement (FOA), CD08-001, 42576-42577 [E8-16725]
Download as PDF
42576
Federal Register / Vol. 73, No. 141 / Tuesday, July 22, 2008 / Notices
that the institution sends a copy of the
certification to ORI; and
(4) to write ORI-approved letters to (a)
collaborators/coauthors of the
manuscripts and published papers cited
above, stating what she falsified/
fabricated and offering restitution; and
(b) editors of the journals in which
papers were published (even if they
have been retracted/corrected) to state
that her falsifications/fabrications were
the underlying reason for the retraction/
correction.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E8–16741 Filed 7–21–08; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Preparedness
and Emergency Response Research
Centers: A Public Health System
Approach-Secondary Review
Committee (SRC), Program
Announcement Number (PA) TP 08–
001
sroberts on PROD1PC70 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 8:30 a.m.–5 p.m., August
7, 2008 (Closed).
Place: CDC, Global Communication Center,
1600 Clifton Road, NE., Atlanta, GA 30333,
(404) 639–3995.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Preparedness and Emergency
Response Research Centers: A Public Health
System Approach-SRC,’’ PA TP 08–001.
For Further Information Contact: Daniel M.
Sosin, M.D., M.P.H., Senior Advisor for
Science, Office of the Director, Coordinating
Office for Terrorism Preparedness and
Emergency Response, CDC, 1600 Clifton
Road, NE., Mailstop K72, Atlanta, GA 30333,
Telephone (770) 488–8806.
The Director, Management Analysis and
Services Office, has been delegated the
VerDate Aug<31>2005
19:47 Jul 21, 2008
Jkt 214001
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–16720 Filed 7–21–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Impact of
Cultural and Socioeconomic Factors
on Post-Treatment Surveillance
Among African Americans With
Colorectal Cancer, Potential
Extramural Project (PEP) 2008–R–03.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 1 p.m.–3 p.m., August 6,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Impact of Cultural and
Socioeconomic Factors on Post-Treatment
Surveillance among African Americans with
Colorectal Cancer, PEP 2008–R–03.’’
For Further Information Contact: Linda
Shelton, Program Specialist, Coordinating
Center for Health and Information Service,
Office of the Director, CDC, 1600 Clifton
Road, NE., Mailstop E21, Atlanta, GA 30333,
Telephone (404)498–1194. The Director,
Management Analysis and Services Office,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
CDC and the Agency for Toxic Substances
and Disease Registry.
Dated: July 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–16721 Filed 7–21–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Elimination of
Health Disparities Through Translation
Research (Panel A–1), Funding
Opportunity Announcement (FOA),
CD08–001
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:30 p.m.–3:30 p.m.,
August 6, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Elimination of Health
Disparities through Translation Research
(Panel A–1), FOA CD08–001.’’
Contact Person for More Information:
Maurine F. Goodman, M.A., M.P.H.,
Scientific Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop D72, Atlanta, GA
30333, Telephone (404) 639–4737.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–16722 Filed 7–21–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Elimination of
Health Disparities Through Translation
Research (Panel D), Funding
Opportunity Announcement (FOA),
CD08–001
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
E:\FR\FM\22JYN1.SGM
22JYN1
Federal Register / Vol. 73, No. 141 / Tuesday, July 22, 2008 / Notices
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:30 p.m.–3:30 p.m.,
August 5, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Elimination of Health
Disparities through Translation Research
(Panel D), FOA CD08–001.’’
Contact person for more information:
Maurine F. Goodman, M.A., M.P.H.,
Scientific Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop D72, Atlanta, GA
30333, Telephone (404) 639–4737.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–16725 Filed 7–21–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–21, CMS–
10150, and CMS–484]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
sroberts on PROD1PC70 with NOTICES
AGENCY:
VerDate Aug<31>2005
19:47 Jul 21, 2008
Jkt 214001
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Withholding
Medicare Payments to Recover
Medicaid Overpayments and
Supporting Regulations in 42 CFR
44.31; Use: Overpayments may occur in
either the Medicare and Medicaid
program, at times resulting in a situation
where an institution or person that
provides services owes a repayment to
one program while still receiving
reimbursement from the other. Certain
Medicaid providers which are subject to
offsets for the collection of Medicaid
overpayments may terminate or
substantially reduce their participation
in Medicaid, leaving the State Medicaid
Agency unable to recover the amounts
due. These information collection
requirements give CMS the authority to
recover Medicaid overpayments by
offsetting payments due to a provider
under the program. Form Number:
CMS–R–21 (OMB# 0938–0287);
Frequency: On occasion; Affected
Public: State, Local or Tribal
Governments; Number of Respondents:
54; Total Annual Responses: 27; Total
Annual Hours: 81.
2. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Collection of
Drug Pricing and Network Pharmacy
Data from Medicare Prescription Drug
Plans (PDPs and MA–PDs) and
Supporting Regulations in 42 CFR
423.48; Use: Both stand alone
prescription drug plans (PDPs) and
Medicare Advantage Prescription Drug
(MA–PDs) plans are required to submit
drug pricing and pharmacy network
data to CMS and these data are made
publicly available to people with
Medicare through the Medicare
Prescription Drug Plan Finder Web tool
on https://www.medicare.gov. Drug
prices vary across a plans pharmacy
network based on the contracts that
each plan negotiates with each
pharmacy or pharmacy chain in their
networks. The pharmacy networks can
change during the course of the year as
new pharmacies open, close, change
ownership, or plans negotiate new
contracts with pharmacies resulting in
different dispensing fees for
prescriptions. Drug prices also change
frequently due to the daily fluctuation
of the Average Wholesale Price (AWP),
thus plans increase or decrease their
drug prices to reflect these changes. The
purpose of the data is to enable
prospective and current Medicare
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
42577
beneficiaries to compare, learn, select
and enroll in a plan that best meets their
needs. The database structure provides
the necessary drug pricing and
pharmacy network information to
accurately communicate plan
information in a comparative format.
Form Number: CMS–10150 (OMB#
0938–0951); Frequency: Bi-weekly;
Affected Public: Business or other forprofits; Number of Respondents: 680;
Total Annual Responses: 17,680; Total
Annual Hours: 70,720.
3. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Durable Medical
Equipment Regional Carrier, Certificate
of Medical Necessity for Oxygen and
Supporting Regulations in 42 CFR
410.38 and 424.5; Use: The oxygen
certificate of medical necessity (CMN)
collects information required to help
determine the medical necessity of
home oxygen therapy for Medicare
beneficiaries. CMS requires CMNs
where items may present a vulnerability
to the Medicare program. Each claim for
these items must have an associated
CMN for the beneficiary. In order to
determine if a beneficiary needs home
oxygen therapy, a qualifying blood gas
study must be performed and it must
comply with the DMERCs Oxygen
Medical Policy on the standards for
conducting the test and also be covered
under Medicare Part B. A beneficiary
must be seen and evaluated by the
treating physician within specific
timeframes as indicated by the Oxygen
Medical Policy in order to complete an
Initial CMN Certification, a
Recertification CMN and a Revised
CMN Certification. Form Number:
CMS–484 (OMB# 0938–0534);
Frequency: Occasionally; Affected
Public: Business or other for-profits;
Number of Respondents: 15,000; Total
Annual Responses: 1,630,000; Total
Annual Hours: 326,000.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’s Web
Site at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by September 22, 2008:
E:\FR\FM\22JYN1.SGM
22JYN1
Agencies
[Federal Register Volume 73, Number 141 (Tuesday, July 22, 2008)]
[Notices]
[Pages 42576-42577]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-16725]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Elimination of Health Disparities Through
Translation Research (Panel D), Funding Opportunity Announcement (FOA),
CD08-001
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease
[[Page 42577]]
Control and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 12:30 p.m.-3:30 p.m., August 5, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of ``Elimination of Health Disparities
through Translation Research (Panel D), FOA CD08-001.''
Contact person for more information: Maurine F. Goodman, M.A.,
M.P.H., Scientific Review Administrator, CDC, 1600 Clifton Road,
NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 639-4737.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-16725 Filed 7-21-08; 8:45 am]
BILLING CODE 4163-18-P